📰 Gravis Foundation News
Gravis Foundation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Gravis Foundation. Real-time updates on events, politics, business and more.
May 1, 2024
The Richard and Helen DeVos Foundation announced Wednesday that it will sunset its work after supporting 1,044 nonprofit organizations in its 54 years of activity.
January 4, 2024
Programs/Self-Help Groups
January 3, 2024
ZILBRYSQ® is now commercially available by prescription in the United States and dispensed by UCBs selected exclusive specialty pharmacy PANTHERx® Rare Pharmacy.ZILBRYSQ is FDA-approved as the...
December 4, 2023
UCB announces European Commission approval of ZILBRYSQ®▼ (zilucoplan) for the treatment of adults with generalized Myasthenia GravisEuropean approval of ZILBRYSQ® (zilucoplan) granted as an add-on to standard therapy for the treatment of generalized Myasthenia Gravis (gMG) in adult patients who are anti-acet...
November 10, 2023
UCB receives CHMP positive opinion for rozanolixizumab for treatment of adults with generalized myasthenia gravis in Europe The Committee for Medicinal...
November 1, 2023
UCB presents latest data from generalized myasthenia gravis portfolio at 2023 AANEM Annual Meeting and MGFA Scientific Session 14 presentations - including 3...
October 19, 2023
Programs/Self-Help Groups
October 18, 2023
FDA approval of ZILBRYSQ® (zilucoplan) has been granted for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-ac...
October 18, 2023
UCB announces U.S. FDA approval of ZILBRYSQ[®] for the treatment of adults with generalized myasthenia gravis FDA approval of ZILBRYSQ® has been granted...
October 17, 2023
FDA approval of ZILBRYSQ® has been granted for the treatment of generalized myasthenia gravis in adult patients who are anti-acetylcholine receptor antibody-positive1ZILBRYSQ is the first...